Tag: Darbepoetin alfa

1. Vadadustat was shown to be non-inferior to darbepoetin alfa in cardiovascular safety for patients with anemia and dialysis-dependent chronic kidney disease (DD-CKD). 2. Vadadustat was shown to present comparable efficacy in normalizing hemoglobin concentration compared to darbepoetin alfa in the patient population. Evidence Rating Level: 1 (Excellent) Study Rundown: Chronic kidney...